InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Golumbeski George, Director. Insider active across 3 companies, notably Shattuck Labs, Inc.. In total, 4 filings have been recorded. Split: 3 buys · 0 sell. Total volume traded: €424k. History available since 21 April 2022. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
4 of 4 declarations
George Golumbeski is a Director at Shattuck Labs, Inc. and Sage Therapeutics, Inc. In these roles, he participates in the governance of the companies and strategic decision-making. Golumbeski brings expertise in biotechnology and drug development, contributing to innovation and performance at the companies.